IRIS
BABUDIERI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.762
AS - Asia 7.878
EU - Europa 5.198
SA - Sud America 4.373
Continente sconosciuto - Info sul continente non disponibili 559
AF - Africa 307
OC - Oceania 27
AN - Antartide 1
Totale 34.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.325
BR - Brasile 3.909
SG - Singapore 3.263
CN - Cina 2.228
UA - Ucraina 1.285
IT - Italia 1.144
DE - Germania 757
HK - Hong Kong 746
VN - Vietnam 559
FR - Francia 452
SE - Svezia 435
FI - Finlandia 304
GB - Regno Unito 261
CA - Canada 174
AR - Argentina 144
IN - India 135
TR - Turchia 133
BD - Bangladesh 127
MX - Messico 111
RU - Federazione Russa 103
IQ - Iraq 102
ZA - Sudafrica 88
EC - Ecuador 85
JP - Giappone 64
MA - Marocco 62
VE - Venezuela 62
CZ - Repubblica Ceca 61
UZ - Uzbekistan 56
AE - Emirati Arabi Uniti 54
PK - Pakistan 54
PL - Polonia 53
ES - Italia 52
CO - Colombia 48
NL - Olanda 47
BE - Belgio 40
PY - Paraguay 40
AT - Austria 38
KE - Kenya 37
ID - Indonesia 33
LT - Lituania 30
NP - Nepal 30
JM - Giamaica 28
KR - Corea 27
TN - Tunisia 27
AU - Australia 26
AZ - Azerbaigian 26
PE - Perù 26
RO - Romania 25
JO - Giordania 24
UY - Uruguay 24
CL - Cile 23
IL - Israele 23
LB - Libano 22
DZ - Algeria 21
SA - Arabia Saudita 21
DO - Repubblica Dominicana 20
PH - Filippine 20
KZ - Kazakistan 18
EG - Egitto 17
HN - Honduras 17
CR - Costa Rica 16
KG - Kirghizistan 16
PS - Palestinian Territory 16
BG - Bulgaria 14
IR - Iran 14
OM - Oman 14
AL - Albania 12
GT - Guatemala 12
NI - Nicaragua 12
RS - Serbia 12
EU - Europa 10
HU - Ungheria 10
IE - Irlanda 10
TT - Trinidad e Tobago 10
CH - Svizzera 9
PA - Panama 9
SN - Senegal 9
BO - Bolivia 8
KW - Kuwait 8
MY - Malesia 8
SV - El Salvador 8
BY - Bielorussia 7
MK - Macedonia 7
XK - ???statistics.table.value.countryCode.XK??? 7
ET - Etiopia 6
GP - Guadalupe 6
NG - Nigeria 6
AO - Angola 5
BN - Brunei Darussalam 5
CW - ???statistics.table.value.countryCode.CW??? 5
QA - Qatar 5
AM - Armenia 4
GE - Georgia 4
PR - Porto Rico 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CI - Costa d'Avorio 3
Totale 33.495
Salva come PNG Salva come JPEG
Città #
Dallas 4.088
Singapore 1.752
Chandler 1.433
San Jose 1.345
Ashburn 967
Jacksonville 742
Hong Kong 732
Council Bluffs 665
Beijing 473
Princeton 468
Santa Clara 390
Columbus 325
New York 318
Nanjing 307
Dearborn 286
São Paulo 269
Lauterbourg 242
Milan 195
Munich 193
Ho Chi Minh City 192
Wilmington 192
Los Angeles 190
Sassari 158
Shanghai 158
Hanoi 148
Boardman 147
Ann Arbor 130
Rio de Janeiro 129
Nanchang 126
Helsinki 114
Belo Horizonte 102
Shenyang 101
Rome 94
Brasília 86
Woodbridge 81
Tianjin 76
Hebei 66
Changsha 60
Atlanta 59
Curitiba 58
Tokyo 58
Brno 56
Porto Alegre 54
Campinas 52
Nuremberg 49
Orem 49
Guarulhos 48
Montreal 48
Toronto 48
Phoenix 47
Warsaw 47
Brooklyn 46
Denver 46
Frankfurt am Main 46
Salvador 46
Tashkent 46
Cagliari 45
Johannesburg 45
San Francisco 44
Buffalo 43
Chicago 41
Goiânia 41
The Dalles 40
Brussels 39
Jiaxing 39
Miano 39
Chennai 37
Guangzhou 36
Ningbo 36
Zhengzhou 36
Jinan 35
Ribeirão Preto 34
Kunming 33
Nairobi 33
Andover 32
London 32
Norwalk 32
Dhaka 31
Guayaquil 31
Houston 31
Baghdad 30
São José dos Campos 30
Fortaleza 29
Seoul 27
Sorocaba 27
Istanbul 26
Santo André 26
Stockholm 26
Asunción 25
Ankara 24
Baku 24
Hangzhou 24
Izmir 23
Palermo 23
Poplar 23
Turku 23
Amman 22
Boston 22
Naples 22
Quito 22
Totale 19.826
Salva come PNG Salva come JPEG
Nome #
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 298
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 294
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 276
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 239
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 226
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 225
A case of vasculitis-like skin eruption associated with COVID-19 220
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 218
Anaerobic bacteria and bacterial infections: perspectives on treatment and resistence in Italy 216
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 212
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 210
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 208
Associazione tra Tubercolosi ed infezione da HIV: programma per uno studio multicentrico 207
Blood born viral infections, sexually transmitted diseases and latent tuberculosis in italian prisons: a preliminary report of a large multicenter study 204
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 199
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 197
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 194
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 193
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 191
Application of a miniaturized system to the study of the intestinal microflora 191
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 186
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 184
An outbreak of Q fever in a prison in Italy 182
Evaluation of EZH2 expression in hepatitis B patients 182
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 182
Association of Tuberculosis risk with the degree of tubercolin reaction in HIV-infected patients 182
A young woman with hepatitis after a sore throat 181
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 178
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 177
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 177
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 173
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 172
Dental care and HIV-infected individuals: are they equally treated? 172
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 171
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 171
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 170
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 167
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 165
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 165
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 165
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 162
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 162
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 157
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 157
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 157
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 155
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 154
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 152
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 151
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 151
An Outbreak of Q fever in a prison in Italy 151
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 151
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 151
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 150
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 149
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 149
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 148
Relazione tra antigenemia ed anticorpi nell'evoluzione dell'infezione da HIV 147
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 147
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 146
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 146
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 146
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 145
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 143
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 143
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 142
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 142
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature 142
Feasibility and efficacy of eight weeks Glecaprevir/Pibrentasvir to treat incarcerated viremic HCV patients: a case-control study 140
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 139
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 139
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 139
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 138
Produzione di linee cellulari ibride per l'isolamento di virus linfotropi 138
Trasmissione eterosessuale dell'infezione da HIV1 nella provincia di Sassari 137
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 136
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 136
Infectious diseases screening approach among refugees: Results from a single-center study 136
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 136
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 135
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 135
Clostridi elicoidali: nuovi patogeni intestinali? Comparazione tra un ceppo umano e ceppi di provenienza animale 135
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 135
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 134
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 134
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study 133
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 132
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 132
L'attività di Imipenem contro i microrganismi anaerobi: studio policentrico su ceppi isolati da infezioni umane e confronto in vitro con altri antibiotici 132
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 131
Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019 131
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 130
Enterococcal infections of the respiratory tract in HIV patients 130
Tache Noire in a Patient with Acute Q Fever 130
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 130
Diarrea associata a Clostridium spiroforme 129
HNK1 perifereal blood lymphocytes in HIV infected patients 129
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 128
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 128
HIV related aneurisms 128
Totale 16.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022922 0 0 0 13 10 15 41 79 89 62 134 479
2022/20232.754 278 161 68 455 299 447 23 321 466 29 113 94
2023/2024904 152 60 24 25 238 117 15 42 1 5 64 161
2024/20258.234 131 90 490 200 315 265 748 1.550 2.729 1.122 342 252
2025/202612.090 496 3.087 1.815 1.625 1.171 664 1.700 324 445 480 199 84
2026/20273.587 235 825 1.102 1.425 0 0 0 0 0 0 0 0
Totale 34.105